

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.50570619 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 6.50570619 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.46027338 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.46027338 |
| 5 | intestinal cholesterol absorption (GO:0030299) | 5.94002663 |
| 6 | serine family amino acid biosynthetic process (GO:0009070) | 5.82704846 |
| 7 | cysteine metabolic process (GO:0006534) | 5.67541998 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.28725130 |
| 9 | * glycine metabolic process (GO:0006544) | 5.19331627 |
| 10 | L-serine metabolic process (GO:0006563) | 5.07506175 |
| 11 | serine family amino acid catabolic process (GO:0009071) | 5.05457964 |
| 12 | glyoxylate metabolic process (GO:0046487) | 4.96247634 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 4.93893107 |
| 14 | homocysteine metabolic process (GO:0050667) | 4.86928536 |
| 15 | * serine family amino acid metabolic process (GO:0009069) | 4.85417971 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.60080156 |
| 17 | regulation of mitochondrial translation (GO:0070129) | 4.44861956 |
| 18 | kynurenine metabolic process (GO:0070189) | 4.39714336 |
| 19 | indole-containing compound catabolic process (GO:0042436) | 4.36016810 |
| 20 | indolalkylamine catabolic process (GO:0046218) | 4.36016810 |
| 21 | tryptophan catabolic process (GO:0006569) | 4.36016810 |
| 22 | bile acid biosynthetic process (GO:0006699) | 4.35839191 |
| 23 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.34464951 |
| 24 | cellular modified amino acid catabolic process (GO:0042219) | 4.23650383 |
| 25 | tryptophan metabolic process (GO:0006568) | 4.18826122 |
| 26 | proline biosynthetic process (GO:0006561) | 4.17917654 |
| 27 | lysine catabolic process (GO:0006554) | 4.14504065 |
| 28 | lysine metabolic process (GO:0006553) | 4.14504065 |
| 29 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.10208517 |
| 30 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.08434992 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 4.05688157 |
| 32 | * alpha-amino acid catabolic process (GO:1901606) | 4.04938681 |
| 33 | urea cycle (GO:0000050) | 4.04045606 |
| 34 | urea metabolic process (GO:0019627) | 4.04045606 |
| 35 | branched-chain amino acid catabolic process (GO:0009083) | 4.00684610 |
| 36 | high-density lipoprotein particle remodeling (GO:0034375) | 3.97892509 |
| 37 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.96496587 |
| 38 | negative regulation of fibrinolysis (GO:0051918) | 3.94365857 |
| 39 | DNA strand elongation (GO:0022616) | 3.92327209 |
| 40 | exocrine pancreas development (GO:0031017) | 3.92281545 |
| 41 | * cellular amino acid catabolic process (GO:0009063) | 3.91863529 |
| 42 | proteasome assembly (GO:0043248) | 3.89770133 |
| 43 | proline metabolic process (GO:0006560) | 3.85898077 |
| 44 | imidazole-containing compound metabolic process (GO:0052803) | 3.84888149 |
| 45 | nitrogen cycle metabolic process (GO:0071941) | 3.81642805 |
| 46 | oxidative phosphorylation (GO:0006119) | 3.80807801 |
| 47 | tetrahydrofolate metabolic process (GO:0046653) | 3.74154668 |
| 48 | one-carbon metabolic process (GO:0006730) | 3.73380269 |
| 49 | alpha-linolenic acid metabolic process (GO:0036109) | 3.72871990 |
| 50 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.70849758 |
| 51 | protein carboxylation (GO:0018214) | 3.70849758 |
| 52 | bile acid metabolic process (GO:0008206) | 3.70754262 |
| 53 | regulation of fibrinolysis (GO:0051917) | 3.70176432 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 3.69354681 |
| 55 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.67652268 |
| 56 | coenzyme catabolic process (GO:0009109) | 3.63118068 |
| 57 | sulfur amino acid biosynthetic process (GO:0000097) | 3.60689350 |
| 58 | intestinal absorption (GO:0050892) | 3.59093105 |
| 59 | aldehyde catabolic process (GO:0046185) | 3.54763004 |
| 60 | branched-chain amino acid metabolic process (GO:0009081) | 3.52178253 |
| 61 | telomere maintenance via recombination (GO:0000722) | 3.51630273 |
| 62 | negative regulation of sterol transport (GO:0032372) | 3.51110850 |
| 63 | negative regulation of cholesterol transport (GO:0032375) | 3.51110850 |
| 64 | regulation of protein activation cascade (GO:2000257) | 3.49766807 |
| 65 | valine metabolic process (GO:0006573) | 3.49551799 |
| 66 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.48391600 |
| 67 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.47084580 |
| 68 | alpha-amino acid biosynthetic process (GO:1901607) | 3.46837637 |
| 69 | folic acid metabolic process (GO:0046655) | 3.43997551 |
| 70 | regulation of cholesterol esterification (GO:0010872) | 3.43781291 |
| 71 | reverse cholesterol transport (GO:0043691) | 3.42730082 |
| 72 | mitotic recombination (GO:0006312) | 3.42117861 |
| 73 | tyrosine metabolic process (GO:0006570) | 3.40539433 |
| 74 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.38454429 |
| 75 | ATP synthesis coupled proton transport (GO:0015986) | 3.36463774 |
| 76 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.36463774 |
| 77 | * carboxylic acid catabolic process (GO:0046395) | 3.36094462 |
| 78 | * organic acid catabolic process (GO:0016054) | 3.36094462 |
| 79 | rRNA modification (GO:0000154) | 3.35348346 |
| 80 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.34359895 |
| 81 | pseudouridine synthesis (GO:0001522) | 3.34238126 |
| 82 | acylglycerol homeostasis (GO:0055090) | 3.33797381 |
| 83 | triglyceride homeostasis (GO:0070328) | 3.33797381 |
| 84 | glutamate metabolic process (GO:0006536) | 3.32837546 |
| 85 | complement activation, alternative pathway (GO:0006957) | 3.32001637 |
| 86 | sterol catabolic process (GO:0016127) | 3.29733712 |
| 87 | cholesterol catabolic process (GO:0006707) | 3.29733712 |
| 88 | plasma lipoprotein particle remodeling (GO:0034369) | 3.28101487 |
| 89 | protein-lipid complex remodeling (GO:0034368) | 3.28101487 |
| 90 | macromolecular complex remodeling (GO:0034367) | 3.28101487 |
| 91 | folic acid-containing compound metabolic process (GO:0006760) | 3.27552275 |
| 92 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.26095555 |
| 93 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.24847020 |
| 94 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.24334606 |
| 95 | ethanol oxidation (GO:0006069) | 3.23367382 |
| 96 | regulation of triglyceride catabolic process (GO:0010896) | 3.23146507 |
| 97 | regulation of complement activation (GO:0030449) | 3.22890123 |
| 98 | response to nitrosative stress (GO:0051409) | 3.20823492 |
| 99 | cellular amino acid biosynthetic process (GO:0008652) | 3.20254671 |
| 100 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.19968952 |
| 101 | sulfur amino acid metabolic process (GO:0000096) | 3.17966113 |
| 102 | establishment of integrated proviral latency (GO:0075713) | 3.17059000 |
| 103 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.16568820 |
| 104 | pteridine-containing compound metabolic process (GO:0042558) | 3.15424366 |
| 105 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.15074152 |
| 106 | DNA replication checkpoint (GO:0000076) | 3.12951151 |
| 107 | phospholipid efflux (GO:0033700) | 3.12885230 |
| 108 | digestion (GO:0007586) | 3.12540631 |
| 109 | negative regulation of ligase activity (GO:0051352) | 3.10328635 |
| 110 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.10328635 |
| 111 | plasma lipoprotein particle clearance (GO:0034381) | 3.09942076 |
| 112 | formation of translation preinitiation complex (GO:0001731) | 3.07935094 |
| 113 | indolalkylamine metabolic process (GO:0006586) | 3.07503519 |
| 114 | cellular ketone body metabolic process (GO:0046950) | 3.07475588 |
| 115 | cellular biogenic amine catabolic process (GO:0042402) | 3.07142189 |
| 116 | amine catabolic process (GO:0009310) | 3.07142189 |
| 117 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.06924622 |
| 118 | protein maturation by protein folding (GO:0022417) | 3.06013318 |
| 119 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.04523704 |
| 120 | CENP-A containing nucleosome assembly (GO:0034080) | 3.04452277 |
| 121 | short-chain fatty acid metabolic process (GO:0046459) | 3.04390436 |
| 122 | 4-hydroxyproline metabolic process (GO:0019471) | 3.03920445 |
| 123 | bile acid and bile salt transport (GO:0015721) | 3.03694797 |
| 124 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.03688021 |
| 125 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.03688021 |
| 126 | benzene-containing compound metabolic process (GO:0042537) | 3.03390120 |
| 127 | protein retention in ER lumen (GO:0006621) | 3.02829845 |
| 128 | tRNA aminoacylation for protein translation (GO:0006418) | 3.00940083 |
| 129 | chromatin remodeling at centromere (GO:0031055) | 3.00662758 |
| 130 | telomere maintenance via telomere lengthening (GO:0010833) | 3.00329030 |
| 131 | * alpha-amino acid metabolic process (GO:1901605) | 3.00133533 |
| 132 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.98450654 |
| 133 | respiratory electron transport chain (GO:0022904) | 2.97864964 |
| 134 | ribosomal large subunit biogenesis (GO:0042273) | 2.97715998 |
| 135 | * aspartate family amino acid catabolic process (GO:0009068) | 2.97626797 |
| 136 | cullin deneddylation (GO:0010388) | 2.97054094 |
| 137 | heme transport (GO:0015886) | 2.96145024 |
| 138 | cholesterol homeostasis (GO:0042632) | 2.95839873 |
| 139 | protein targeting to mitochondrion (GO:0006626) | 2.95809444 |
| 140 | cellular glucuronidation (GO:0052695) | 2.95623622 |
| 141 | tricarboxylic acid cycle (GO:0006099) | 2.93952260 |
| 142 | DNA unwinding involved in DNA replication (GO:0006268) | 2.92943704 |
| 143 | mitotic metaphase plate congression (GO:0007080) | 2.92364015 |
| 144 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.91626773 |
| 145 | mitotic sister chromatid segregation (GO:0000070) | 2.91154464 |
| 146 | DNA replication initiation (GO:0006270) | 2.90961192 |
| 147 | protein complex biogenesis (GO:0070271) | 2.90628664 |
| 148 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.90539200 |
| 149 | tRNA aminoacylation (GO:0043039) | 2.89741255 |
| 150 | amino acid activation (GO:0043038) | 2.89741255 |
| 151 | electron transport chain (GO:0022900) | 2.89462928 |
| 152 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.85974439 |
| 153 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.85450505 |
| 154 | chaperone-mediated protein transport (GO:0072321) | 2.83896039 |
| 155 | regulation of translational fidelity (GO:0006450) | 2.83725156 |
| 156 | purine nucleobase biosynthetic process (GO:0009113) | 2.83065965 |
| 157 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.82352083 |
| 158 | iron-sulfur cluster assembly (GO:0016226) | 2.82055444 |
| 159 | metallo-sulfur cluster assembly (GO:0031163) | 2.82055444 |
| 160 | peptidyl-histidine modification (GO:0018202) | 2.81798130 |
| 161 | heme biosynthetic process (GO:0006783) | 2.81427887 |
| 162 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.81181868 |
| 163 | kinetochore assembly (GO:0051382) | 2.80878176 |
| 164 | establishment of viral latency (GO:0019043) | 2.78070096 |
| 165 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.77671384 |
| 166 | NADH dehydrogenase complex assembly (GO:0010257) | 2.77671384 |
| 167 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.77671384 |
| 168 | DNA ligation (GO:0006266) | 2.77649867 |
| 169 | ribosome assembly (GO:0042255) | 2.77446398 |
| 170 | ubiquinone biosynthetic process (GO:0006744) | 2.77230855 |
| 171 | base-excision repair (GO:0006284) | 2.76813539 |
| 172 | nucleobase biosynthetic process (GO:0046112) | 2.75682993 |
| 173 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.75665954 |
| 174 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.75593545 |
| 175 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.75593545 |
| 176 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.75593545 |
| 177 | base-excision repair, AP site formation (GO:0006285) | 2.74764061 |
| 178 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.74420262 |
| 179 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.74020319 |
| 180 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.74020319 |
| 181 | protein deneddylation (GO:0000338) | 2.73520389 |
| 182 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.72666144 |
| 183 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.72666144 |
| 184 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.72195901 |
| 185 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.72195901 |
| 186 | respiratory chain complex IV assembly (GO:0008535) | 2.71207073 |
| 187 | positive regulation of ligase activity (GO:0051351) | 2.70978019 |
| 188 | establishment of protein localization to mitochondrion (GO:0072655) | 2.70701385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.76528526 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.58263186 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.19413269 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.74561841 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.63849392 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.23138108 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.22685701 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.06759158 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.94882034 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.89321291 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.86798107 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.86630574 |
| 13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.49308411 |
| 14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.32199538 |
| 15 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.26599326 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.22885282 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.19246014 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.18400106 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.15455037 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.11685321 |
| 21 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.07214459 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.03483049 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.02979042 |
| 24 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.97164333 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94312443 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.88020960 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.86184836 |
| 28 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.85249430 |
| 29 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.77834393 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.77556715 |
| 31 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.63049350 |
| 32 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.61676768 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.59560027 |
| 34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.57584251 |
| 35 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.56681454 |
| 36 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.55315978 |
| 37 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.55165682 |
| 38 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.54745173 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.52035625 |
| 40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.51616766 |
| 41 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.50597190 |
| 42 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.46311424 |
| 43 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.45973758 |
| 44 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45935911 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.44332361 |
| 46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43127341 |
| 47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41751732 |
| 48 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.41717116 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.41085832 |
| 50 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.39437166 |
| 51 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.39235249 |
| 52 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.39235249 |
| 53 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.39235249 |
| 54 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.34921400 |
| 55 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.33491023 |
| 56 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.30927301 |
| 57 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28912101 |
| 58 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.27045336 |
| 59 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.25348952 |
| 60 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.23305674 |
| 61 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22709783 |
| 62 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.22522830 |
| 63 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.21900073 |
| 64 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.21469714 |
| 65 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.18579445 |
| 66 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.18393063 |
| 67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.17574170 |
| 68 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.17186572 |
| 69 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.16646343 |
| 70 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.16300649 |
| 71 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.16034976 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.14485828 |
| 73 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13926991 |
| 74 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.12769192 |
| 75 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.11672972 |
| 76 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.10064065 |
| 77 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.09735420 |
| 78 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09606238 |
| 79 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.09306510 |
| 80 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.08946733 |
| 81 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.08877173 |
| 82 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.08242603 |
| 83 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.06818225 |
| 84 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04093323 |
| 85 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03067092 |
| 86 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.02921321 |
| 87 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.02861113 |
| 88 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.01905616 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01496686 |
| 90 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.00071547 |
| 91 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98754753 |
| 92 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.98693754 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98473971 |
| 94 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98442407 |
| 95 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.98338971 |
| 96 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98268664 |
| 97 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97471334 |
| 98 | * MYC_18940864_ChIP-ChIP_HL60_Human | 0.97140623 |
| 99 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.96642979 |
| 100 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95468504 |
| 101 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.94677006 |
| 102 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94587811 |
| 103 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94516579 |
| 104 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90027673 |
| 105 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89618042 |
| 106 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.88020045 |
| 107 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87965756 |
| 108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86902134 |
| 109 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.86273281 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85841524 |
| 111 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.84620866 |
| 112 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.84460576 |
| 113 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.84408316 |
| 114 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.84349393 |
| 115 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83698431 |
| 116 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83407895 |
| 117 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82680519 |
| 118 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.82470582 |
| 119 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.81901380 |
| 120 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.79591384 |
| 121 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78708650 |
| 122 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.78517306 |
| 123 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.78282984 |
| 124 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.77793891 |
| 125 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.77745817 |
| 126 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77648786 |
| 127 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.77498428 |
| 128 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.76753522 |
| 129 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76447076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.32068369 |
| 2 | MP0005365_abnormal_bile_salt | 6.04727584 |
| 3 | MP0005360_urolithiasis | 5.79186254 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.47476675 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.91644448 |
| 6 | MP0005083_abnormal_biliary_tract | 4.79743562 |
| 7 | MP0001666_abnormal_nutrient_absorption | 4.38598608 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.50606290 |
| 9 | MP0009840_abnormal_foam_cell | 2.73386487 |
| 10 | MP0003252_abnormal_bile_duct | 2.71270025 |
| 11 | MP0005332_abnormal_amino_acid | 2.70463982 |
| 12 | MP0000372_irregular_coat_pigmentation | 2.68371510 |
| 13 | MP0005220_abnormal_exocrine_pancreas | 2.68184885 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.55523117 |
| 15 | MP0003868_abnormal_feces_composition | 2.17236511 |
| 16 | MP0003195_calcinosis | 2.14079631 |
| 17 | MP0003786_premature_aging | 2.13350934 |
| 18 | MP0006292_abnormal_olfactory_placode | 2.09967221 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 1.95410129 |
| 20 | MP0002822_catalepsy | 1.91109854 |
| 21 | MP0003136_yellow_coat_color | 1.87676672 |
| 22 | MP0004233_abnormal_muscle_weight | 1.80198311 |
| 23 | MP0008007_abnormal_cellular_replicative | 1.78396488 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.77847760 |
| 25 | MP0001764_abnormal_homeostasis | 1.77584485 |
| 26 | MP0004147_increased_porphyrin_level | 1.77342149 |
| 27 | MP0003186_abnormal_redox_activity | 1.76370994 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.71485953 |
| 29 | MP0000609_abnormal_liver_physiology | 1.64821584 |
| 30 | MP0005171_absent_coat_pigmentation | 1.64511285 |
| 31 | MP0005084_abnormal_gallbladder_morpholo | 1.59234669 |
| 32 | MP0005451_abnormal_body_composition | 1.59169995 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.50310258 |
| 34 | MP0001529_abnormal_vocalization | 1.48839323 |
| 35 | MP0003693_abnormal_embryo_hatching | 1.48739513 |
| 36 | MP0000358_abnormal_cell_content/ | 1.46368702 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.44860243 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.42321623 |
| 39 | MP0003011_delayed_dark_adaptation | 1.37074508 |
| 40 | MP0002796_impaired_skin_barrier | 1.33799218 |
| 41 | MP0002938_white_spotting | 1.33523668 |
| 42 | MP0003646_muscle_fatigue | 1.32676502 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.29494770 |
| 44 | MP0004957_abnormal_blastocyst_morpholog | 1.28924675 |
| 45 | MP0001697_abnormal_embryo_size | 1.21437803 |
| 46 | MP0001293_anophthalmia | 1.21318261 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.19052582 |
| 48 | MP0003718_maternal_effect | 1.17179705 |
| 49 | MP0002234_abnormal_pharynx_morphology | 1.16669326 |
| 50 | MP0000598_abnormal_liver_morphology | 1.15953197 |
| 51 | MP0005408_hypopigmentation | 1.13493480 |
| 52 | MP0004264_abnormal_extraembryonic_tissu | 1.12223109 |
| 53 | MP0001929_abnormal_gametogenesis | 1.12149963 |
| 54 | MP0002736_abnormal_nociception_after | 1.11987304 |
| 55 | MP0000350_abnormal_cell_proliferation | 1.11588534 |
| 56 | MP0008260_abnormal_autophagy | 1.10256475 |
| 57 | MP0005330_cardiomyopathy | 1.06605882 |
| 58 | MP0002210_abnormal_sex_determination | 1.04701972 |
| 59 | MP0001672_abnormal_embryogenesis/_devel | 1.01383180 |
| 60 | MP0005380_embryogenesis_phenotype | 1.01383180 |
| 61 | MP0002254_reproductive_system_inflammat | 0.98278697 |
| 62 | MP0002160_abnormal_reproductive_system | 0.97543852 |
| 63 | MP0000751_myopathy | 0.97094516 |
| 64 | MP0008789_abnormal_olfactory_epithelium | 0.95373092 |
| 65 | MP0000653_abnormal_sex_gland | 0.95069145 |
| 66 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92845193 |
| 67 | MP0001145_abnormal_male_reproductive | 0.92599264 |
| 68 | MP0010030_abnormal_orbit_morphology | 0.92359325 |
| 69 | MP0008995_early_reproductive_senescence | 0.91692655 |
| 70 | MP0000749_muscle_degeneration | 0.88607935 |
| 71 | MP0005501_abnormal_skin_physiology | 0.88134451 |
| 72 | MP0000313_abnormal_cell_death | 0.88109988 |
| 73 | MP0003315_abnormal_perineum_morphology | 0.87573653 |
| 74 | MP0004133_heterotaxia | 0.87146708 |
| 75 | MP0005410_abnormal_fertilization | 0.86289428 |
| 76 | MP0005636_abnormal_mineral_homeostasis | 0.85866321 |
| 77 | MP0009053_abnormal_anal_canal | 0.85786015 |
| 78 | MP0009697_abnormal_copulation | 0.85685418 |
| 79 | MP0002132_abnormal_respiratory_system | 0.85384764 |
| 80 | MP0003698_abnormal_male_reproductive | 0.85229821 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.84467318 |
| 82 | MP0002269_muscular_atrophy | 0.83739388 |
| 83 | MP0003638_abnormal_response/metabolism_ | 0.82675618 |
| 84 | MP0005646_abnormal_pituitary_gland | 0.80827882 |
| 85 | MP0003111_abnormal_nucleus_morphology | 0.80706891 |
| 86 | MP0003984_embryonic_growth_retardation | 0.80578636 |
| 87 | MP0002098_abnormal_vibrissa_morphology | 0.78889651 |
| 88 | MP0002085_abnormal_embryonic_tissue | 0.78760407 |
| 89 | MP0002161_abnormal_fertility/fecundity | 0.76488265 |
| 90 | MP0000678_abnormal_parathyroid_gland | 0.76407295 |
| 91 | MP0001944_abnormal_pancreas_morphology | 0.76051102 |
| 92 | MP0002088_abnormal_embryonic_growth/wei | 0.75763810 |
| 93 | MP0005075_abnormal_melanosome_morpholog | 0.75695089 |
| 94 | MP0005266_abnormal_metabolism | 0.75652242 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 0.75409757 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.75016107 |
| 97 | MP0009672_abnormal_birth_weight | 0.74987091 |
| 98 | MP0003283_abnormal_digestive_organ | 0.74906082 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 0.74892207 |
| 100 | MP0002078_abnormal_glucose_homeostasis | 0.71252933 |
| 101 | MP0009763_increased_sensitivity_to | 0.71022544 |
| 102 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70029224 |
| 103 | MP0001756_abnormal_urination | 0.69307779 |
| 104 | MP0002084_abnormal_developmental_patter | 0.69168199 |
| 105 | MP0003937_abnormal_limbs/digits/tail_de | 0.67583320 |
| 106 | MP0009379_abnormal_foot_pigmentation | 0.67062712 |
| 107 | MP0003077_abnormal_cell_cycle | 0.66590495 |
| 108 | MP0003959_abnormal_lean_body | 0.66355111 |
| 109 | MP0002060_abnormal_skin_morphology | 0.65934698 |
| 110 | MP0009642_abnormal_blood_homeostasis | 0.65752028 |
| 111 | MP0010094_abnormal_chromosome_stability | 0.64976327 |
| 112 | MP0000566_synostosis | 0.64901654 |
| 113 | MP0005647_abnormal_sex_gland | 0.64776958 |
| 114 | MP0005376_homeostasis/metabolism_phenot | 0.64701893 |
| 115 | MP0001119_abnormal_female_reproductive | 0.64655697 |
| 116 | MP0003699_abnormal_female_reproductive | 0.64634167 |
| 117 | MP0000015_abnormal_ear_pigmentation | 0.64526907 |
| 118 | MP0005377_hearing/vestibular/ear_phenot | 0.63278800 |
| 119 | MP0003878_abnormal_ear_physiology | 0.63278800 |
| 120 | MP0003137_abnormal_impulse_conducting | 0.61918610 |
| 121 | MP0004145_abnormal_muscle_electrophysio | 0.61755663 |
| 122 | MP0000579_abnormal_nail_morphology | 0.61485633 |
| 123 | MP0002090_abnormal_vision | 0.60918357 |
| 124 | MP0004381_abnormal_hair_follicle | 0.59339468 |
| 125 | MP0005499_abnormal_olfactory_system | 0.59146049 |
| 126 | MP0005394_taste/olfaction_phenotype | 0.59146049 |
| 127 | MP0003941_abnormal_skin_development | 0.58650115 |
| 128 | MP0003453_abnormal_keratinocyte_physiol | 0.58512796 |
| 129 | MP0001730_embryonic_growth_arrest | 0.58459534 |
| 130 | MP0003119_abnormal_digestive_system | 0.58289647 |
| 131 | MP0001727_abnormal_embryo_implantation | 0.58175010 |
| 132 | MP0002019_abnormal_tumor_incidence | 0.57666679 |
| 133 | MP0005448_abnormal_energy_balance | 0.56209996 |
| 134 | MP0008469_abnormal_protein_level | 0.55650969 |
| 135 | MP0000377_abnormal_hair_follicle | 0.55258724 |
| 136 | MP0003656_abnormal_erythrocyte_physiolo | 0.54775044 |
| 137 | MP0005395_other_phenotype | 0.54005977 |
| 138 | MP0000467_abnormal_esophagus_morphology | 0.53041990 |
| 139 | MP0001216_abnormal_epidermal_layer | 0.52439969 |
| 140 | MP0008932_abnormal_embryonic_tissue | 0.52233391 |
| 141 | MP0003890_abnormal_embryonic-extraembry | 0.50721394 |
| 142 | MP0001243_abnormal_dermal_layer | 0.49407243 |
| 143 | MP0005670_abnormal_white_adipose | 0.49121988 |
| 144 | MP0010352_gastrointestinal_tract_polyps | 0.48844876 |
| 145 | MP0000647_abnormal_sebaceous_gland | 0.47738972 |
| 146 | MP0003123_paternal_imprinting | 0.46861429 |
| 147 | MP0002249_abnormal_larynx_morphology | 0.46580711 |
| 148 | MP0004043_abnormal_pH_regulation | 0.46262486 |
| 149 | MP0008058_abnormal_DNA_repair | 0.45287502 |
| 150 | MP0000367_abnormal_coat/_hair | 0.44239096 |
| 151 | MP0001661_extended_life_span | 0.43971514 |
| 152 | MP0002136_abnormal_kidney_physiology | 0.43632769 |
| 153 | MP0005023_abnormal_wound_healing | 0.43424435 |
| 154 | MP0008873_increased_physiological_sensi | 0.42430729 |
| 155 | MP0000613_abnormal_salivary_gland | 0.42015923 |
| 156 | MP0002111_abnormal_tail_morphology | 0.41542742 |
| 157 | MP0003953_abnormal_hormone_level | 0.38285852 |
| 158 | MP0002080_prenatal_lethality | 0.37571603 |
| 159 | MP0009931_abnormal_skin_appearance | 0.36701397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.88326792 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.98545344 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.86950053 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.57613047 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.03225225 |
| 6 | Hyperglycinemia (HP:0002154) | 4.84346910 |
| 7 | Xanthomatosis (HP:0000991) | 4.81565194 |
| 8 | Hyperglycinuria (HP:0003108) | 4.49976042 |
| 9 | Fat malabsorption (HP:0002630) | 4.48033385 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.46078896 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.42031261 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.36810219 |
| 13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.36810219 |
| 14 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.36309048 |
| 15 | Hyperammonemia (HP:0001987) | 4.34870897 |
| 16 | Acute necrotizing encephalopathy (HP:0006965) | 4.30364590 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.29870475 |
| 18 | Ketosis (HP:0001946) | 4.24788163 |
| 19 | Hypoglycemic coma (HP:0001325) | 4.17381910 |
| 20 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.16207227 |
| 21 | Hepatocellular necrosis (HP:0001404) | 4.12109862 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.06310927 |
| 23 | Steatorrhea (HP:0002570) | 3.94500503 |
| 24 | Hypolipoproteinemia (HP:0010981) | 3.90666319 |
| 25 | Increased CSF lactate (HP:0002490) | 3.78483996 |
| 26 | Mitochondrial inheritance (HP:0001427) | 3.77998267 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 3.74616185 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.72125017 |
| 29 | Microvesicular hepatic steatosis (HP:0001414) | 3.60255100 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.52562442 |
| 31 | Abnormality of serum amino acid levels (HP:0003112) | 3.38303904 |
| 32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.37780865 |
| 33 | Abnormal gallbladder physiology (HP:0012438) | 3.36448650 |
| 34 | Cholecystitis (HP:0001082) | 3.36448650 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.35496276 |
| 36 | Delayed CNS myelination (HP:0002188) | 3.31077606 |
| 37 | Ketoacidosis (HP:0001993) | 3.27896243 |
| 38 | Progressive macrocephaly (HP:0004481) | 3.27550737 |
| 39 | Gout (HP:0001997) | 3.25142785 |
| 40 | Increased serum lactate (HP:0002151) | 3.21136537 |
| 41 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.19738072 |
| 42 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.19738072 |
| 43 | Type I transferrin isoform profile (HP:0003642) | 3.11856666 |
| 44 | Lethargy (HP:0001254) | 3.07358882 |
| 45 | Complement deficiency (HP:0004431) | 3.06846626 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.06284482 |
| 47 | Epidermoid cyst (HP:0200040) | 3.02076347 |
| 48 | Hypoalphalipoproteinemia (HP:0003233) | 2.99805170 |
| 49 | Increased intramyocellular lipid droplets (HP:0012240) | 2.99722374 |
| 50 | Cerebral edema (HP:0002181) | 2.99465127 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 2.99394491 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.99394491 |
| 53 | Ragged-red muscle fibers (HP:0003200) | 2.98759293 |
| 54 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95703221 |
| 55 | Joint hemorrhage (HP:0005261) | 2.91113091 |
| 56 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.89688096 |
| 57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.88904205 |
| 58 | Exercise intolerance (HP:0003546) | 2.81526536 |
| 59 | Late onset (HP:0003584) | 2.80890802 |
| 60 | Conjugated hyperbilirubinemia (HP:0002908) | 2.72863906 |
| 61 | Lipid accumulation in hepatocytes (HP:0006561) | 2.72219326 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.71721151 |
| 63 | Increased muscle lipid content (HP:0009058) | 2.70589158 |
| 64 | Spastic diplegia (HP:0001264) | 2.70508391 |
| 65 | Increased hepatocellular lipid droplets (HP:0006565) | 2.68276274 |
| 66 | Cerebral hypomyelination (HP:0006808) | 2.65710002 |
| 67 | Abnormal protein glycosylation (HP:0012346) | 2.65362830 |
| 68 | Abnormal glycosylation (HP:0012345) | 2.65362830 |
| 69 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.65362830 |
| 70 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.65362830 |
| 71 | Megaloblastic anemia (HP:0001889) | 2.62364822 |
| 72 | Hyperbilirubinemia (HP:0002904) | 2.59506971 |
| 73 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.58481196 |
| 74 | Respiratory failure (HP:0002878) | 2.57003303 |
| 75 | Birth length less than 3rd percentile (HP:0003561) | 2.56605529 |
| 76 | Hypercholesterolemia (HP:0003124) | 2.53851131 |
| 77 | Generalized aminoaciduria (HP:0002909) | 2.52791002 |
| 78 | Metabolic acidosis (HP:0001942) | 2.51533428 |
| 79 | Opisthotonus (HP:0002179) | 2.46651003 |
| 80 | Pancreatitis (HP:0001733) | 2.46599348 |
| 81 | Abnormality of complement system (HP:0005339) | 2.44469704 |
| 82 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.37975267 |
| 83 | Abnormality of purine metabolism (HP:0004352) | 2.35451218 |
| 84 | Malnutrition (HP:0004395) | 2.35440729 |
| 85 | Cholelithiasis (HP:0001081) | 2.34027358 |
| 86 | Renal Fanconi syndrome (HP:0001994) | 2.34013883 |
| 87 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.32361438 |
| 88 | Abnormality of alanine metabolism (HP:0010916) | 2.32361438 |
| 89 | Hyperalaninemia (HP:0003348) | 2.32361438 |
| 90 | Abnormal number of erythroid precursors (HP:0012131) | 2.29444837 |
| 91 | Chromsome breakage (HP:0040012) | 2.28973552 |
| 92 | Microretrognathia (HP:0000308) | 2.23910585 |
| 93 | Hypokinesia (HP:0002375) | 2.23274109 |
| 94 | Abnormal cartilage morphology (HP:0002763) | 2.22914580 |
| 95 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.22274881 |
| 96 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.22274881 |
| 97 | Testicular atrophy (HP:0000029) | 2.20646720 |
| 98 | Hepatic necrosis (HP:0002605) | 2.19103346 |
| 99 | Hepatocellular carcinoma (HP:0001402) | 2.18313839 |
| 100 | Irritability (HP:0000737) | 2.17348428 |
| 101 | Vascular calcification (HP:0004934) | 2.16979615 |
| 102 | Hypoplastic pelvis (HP:0008839) | 2.14647412 |
| 103 | Emotional lability (HP:0000712) | 2.14137074 |
| 104 | Leukodystrophy (HP:0002415) | 2.12546655 |
| 105 | Macrocytic anemia (HP:0001972) | 2.12325854 |
| 106 | Oral leukoplakia (HP:0002745) | 2.11932934 |
| 107 | Multiple enchondromatosis (HP:0005701) | 2.11468173 |
| 108 | Proximal tubulopathy (HP:0000114) | 2.10113516 |
| 109 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.09613945 |
| 110 | Hyperthyroidism (HP:0000836) | 2.09392603 |
| 111 | Vomiting (HP:0002013) | 2.08798222 |
| 112 | Meckel diverticulum (HP:0002245) | 2.07498558 |
| 113 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.06726153 |
| 114 | Type I diabetes mellitus (HP:0100651) | 2.04803700 |
| 115 | Premature ovarian failure (HP:0008209) | 2.04287464 |
| 116 | Acute encephalopathy (HP:0006846) | 2.04135723 |
| 117 | Abnormality of the preputium (HP:0100587) | 2.03649143 |
| 118 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.03003729 |
| 119 | Respiratory difficulties (HP:0002880) | 2.01749064 |
| 120 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.00601105 |
| 121 | Glycosuria (HP:0003076) | 2.00296556 |
| 122 | Abnormality of urine glucose concentration (HP:0011016) | 2.00296556 |
| 123 | 3-Methylglutaconic aciduria (HP:0003535) | 1.99427099 |
| 124 | Abnormality of glycolysis (HP:0004366) | 1.99028216 |
| 125 | Increased serum pyruvate (HP:0003542) | 1.99028216 |
| 126 | Cerebral palsy (HP:0100021) | 1.98937247 |
| 127 | Reticulocytosis (HP:0001923) | 1.96748682 |
| 128 | Abnormality of reticulocytes (HP:0004312) | 1.96685644 |
| 129 | CNS hypomyelination (HP:0003429) | 1.95844206 |
| 130 | Spastic paraparesis (HP:0002313) | 1.95599590 |
| 131 | Abnormality of the ileum (HP:0001549) | 1.94441030 |
| 132 | Myocardial infarction (HP:0001658) | 1.93830209 |
| 133 | Brushfield spots (HP:0001088) | 1.93153449 |
| 134 | Truncus arteriosus (HP:0001660) | 1.92555872 |
| 135 | Secondary amenorrhea (HP:0000869) | 1.91038182 |
| 136 | Increased purine levels (HP:0004368) | 1.90145689 |
| 137 | Hyperuricemia (HP:0002149) | 1.90145689 |
| 138 | Redundant skin (HP:0001582) | 1.89223138 |
| 139 | Abnormality of vitamin metabolism (HP:0100508) | 1.88575433 |
| 140 | Neonatal onset (HP:0003623) | 1.87541977 |
| 141 | Skin nodule (HP:0200036) | 1.87464479 |
| 142 | Symptomatic seizures (HP:0011145) | 1.85460624 |
| 143 | Degeneration of anterior horn cells (HP:0002398) | 1.85130502 |
| 144 | Abnormality of the anterior horn cell (HP:0006802) | 1.85130502 |
| 145 | Nausea (HP:0002018) | 1.84425858 |
| 146 | Cardiovascular calcification (HP:0011915) | 1.81948552 |
| 147 | Methylmalonic aciduria (HP:0012120) | 1.81749709 |
| 148 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81500024 |
| 149 | Horseshoe kidney (HP:0000085) | 1.79584419 |
| 150 | Rhabdomyolysis (HP:0003201) | 1.78960556 |
| 151 | CNS demyelination (HP:0007305) | 1.76497412 |
| 152 | Abnormality of the gallbladder (HP:0005264) | 1.75867387 |
| 153 | Acute hepatic failure (HP:0006554) | 1.75327875 |
| 154 | Rickets (HP:0002748) | 1.75158236 |
| 155 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.74330122 |
| 156 | Optic disc pallor (HP:0000543) | 1.73508764 |
| 157 | Esophageal varix (HP:0002040) | 1.72997603 |
| 158 | Small intestinal stenosis (HP:0012848) | 1.72832606 |
| 159 | Duodenal stenosis (HP:0100867) | 1.72832606 |
| 160 | Hyperglycemia (HP:0003074) | 1.71323170 |
| 161 | Reticulocytopenia (HP:0001896) | 1.70634764 |
| 162 | Rough bone trabeculation (HP:0100670) | 1.69648837 |
| 163 | Abnormal hemoglobin (HP:0011902) | 1.68744487 |
| 164 | Carpal bone hypoplasia (HP:0001498) | 1.67831233 |
| 165 | Abnormal gallbladder morphology (HP:0012437) | 1.66255398 |
| 166 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.66136239 |
| 167 | Progressive muscle weakness (HP:0003323) | 1.64929232 |
| 168 | Lactic acidosis (HP:0003128) | 1.62383326 |
| 169 | Reduced antithrombin III activity (HP:0001976) | 1.61708804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 8.06538736 |
| 2 | VRK2 | 3.92224782 |
| 3 | ERN1 | 3.89106376 |
| 4 | BUB1 | 3.27350915 |
| 5 | ZAK | 2.84741452 |
| 6 | EIF2AK1 | 2.31340750 |
| 7 | TLK1 | 2.31261801 |
| 8 | NME2 | 2.30021688 |
| 9 | WEE1 | 2.28563589 |
| 10 | EIF2AK3 | 2.27823922 |
| 11 | ARAF | 2.13105001 |
| 12 | PKN2 | 2.06520302 |
| 13 | FLT3 | 1.91845788 |
| 14 | PASK | 1.85293474 |
| 15 | SIK1 | 1.78649796 |
| 16 | PIM2 | 1.78335214 |
| 17 | FGFR4 | 1.78126294 |
| 18 | TRIB3 | 1.76719136 |
| 19 | STK16 | 1.75184004 |
| 20 | MAP2K2 | 1.71044628 |
| 21 | RPS6KB2 | 1.60440598 |
| 22 | EPHA2 | 1.54661044 |
| 23 | TESK2 | 1.53384415 |
| 24 | TTK | 1.47067482 |
| 25 | CCNB1 | 1.46699698 |
| 26 | NEK1 | 1.45577311 |
| 27 | CSNK1G3 | 1.39338646 |
| 28 | MAPKAPK3 | 1.35839426 |
| 29 | MST1R | 1.32050082 |
| 30 | SMG1 | 1.32008831 |
| 31 | PBK | 1.28820534 |
| 32 | INSRR | 1.28620266 |
| 33 | MET | 1.26910787 |
| 34 | NEK2 | 1.24076135 |
| 35 | MAP3K11 | 1.23806148 |
| 36 | MAPK11 | 1.22129194 |
| 37 | MAP3K3 | 1.21417633 |
| 38 | MAPKAPK5 | 1.16706360 |
| 39 | CSNK1A1L | 1.15594711 |
| 40 | ERBB4 | 1.15361206 |
| 41 | STK38L | 1.13665764 |
| 42 | LIMK1 | 1.12490690 |
| 43 | AURKA | 1.12024331 |
| 44 | CSNK1G1 | 1.11924037 |
| 45 | CDC7 | 1.11597583 |
| 46 | NUAK1 | 1.11200847 |
| 47 | MAP3K8 | 1.10691041 |
| 48 | KDR | 1.07546950 |
| 49 | MAPK15 | 1.06243205 |
| 50 | PLK1 | 1.03801743 |
| 51 | RAF1 | 1.02621077 |
| 52 | MAP3K10 | 0.99790409 |
| 53 | CDK8 | 0.98884678 |
| 54 | SCYL2 | 0.97681138 |
| 55 | BRSK2 | 0.95548848 |
| 56 | CSNK1G2 | 0.95280306 |
| 57 | AURKB | 0.95152035 |
| 58 | CDK7 | 0.94008773 |
| 59 | ACVR1B | 0.93697563 |
| 60 | TSSK6 | 0.89032522 |
| 61 | VRK1 | 0.88553472 |
| 62 | PRKD3 | 0.88473334 |
| 63 | PIK3CG | 0.87987855 |
| 64 | IRAK3 | 0.85631164 |
| 65 | PTK6 | 0.83828087 |
| 66 | ABL2 | 0.83070019 |
| 67 | CDK4 | 0.81491254 |
| 68 | BRAF | 0.80843114 |
| 69 | DAPK1 | 0.79857211 |
| 70 | LATS1 | 0.76073613 |
| 71 | PRKCI | 0.75323308 |
| 72 | SRPK1 | 0.74147470 |
| 73 | LRRK2 | 0.73302222 |
| 74 | MAP2K6 | 0.72376403 |
| 75 | TAF1 | 0.70032972 |
| 76 | DYRK1B | 0.68279261 |
| 77 | BRSK1 | 0.67163625 |
| 78 | PAK4 | 0.67005720 |
| 79 | EEF2K | 0.66243610 |
| 80 | PLK4 | 0.65998014 |
| 81 | TGFBR1 | 0.65678317 |
| 82 | DYRK3 | 0.64685575 |
| 83 | ATM | 0.63794251 |
| 84 | RPS6KA4 | 0.63764394 |
| 85 | EIF2AK2 | 0.63461888 |
| 86 | MST4 | 0.63164830 |
| 87 | ILK | 0.62089210 |
| 88 | STK10 | 0.60908677 |
| 89 | DAPK3 | 0.60855767 |
| 90 | RPS6KA5 | 0.58610296 |
| 91 | MTOR | 0.57573975 |
| 92 | NME1 | 0.57434315 |
| 93 | LATS2 | 0.56566733 |
| 94 | CSNK2A2 | 0.55989283 |
| 95 | CSNK2A1 | 0.54452639 |
| 96 | TAOK2 | 0.54327995 |
| 97 | MAP2K3 | 0.54022377 |
| 98 | PDK4 | 0.53945421 |
| 99 | PDK3 | 0.53945421 |
| 100 | TAOK3 | 0.51690579 |
| 101 | CDK1 | 0.51330049 |
| 102 | CDK6 | 0.50951987 |
| 103 | ATR | 0.50816676 |
| 104 | PLK2 | 0.50084880 |
| 105 | DYRK2 | 0.46298200 |
| 106 | CLK1 | 0.46151091 |
| 107 | GRK6 | 0.45201851 |
| 108 | ZAP70 | 0.44839872 |
| 109 | CDK11A | 0.44419255 |
| 110 | CHEK2 | 0.44015581 |
| 111 | TYK2 | 0.43732688 |
| 112 | NEK9 | 0.42731858 |
| 113 | CAMK2G | 0.42364089 |
| 114 | TESK1 | 0.42144244 |
| 115 | CDK14 | 0.40704051 |
| 116 | MYLK | 0.40385298 |
| 117 | CSNK1E | 0.39793897 |
| 118 | STK4 | 0.39723462 |
| 119 | PAK2 | 0.39472233 |
| 120 | CDK15 | 0.38674504 |
| 121 | CDK18 | 0.36774461 |
| 122 | PAK6 | 0.35445122 |
| 123 | AKT2 | 0.35095441 |
| 124 | PDK2 | 0.34218833 |
| 125 | PTK2 | 0.33848437 |
| 126 | CHEK1 | 0.32900131 |
| 127 | MELK | 0.32779321 |
| 128 | ERBB2 | 0.31181692 |
| 129 | IRAK2 | 0.30809202 |
| 130 | CDK2 | 0.30318659 |
| 131 | FRK | 0.30292225 |
| 132 | MAP2K1 | 0.30231249 |
| 133 | MAP4K2 | 0.29305099 |
| 134 | PHKG1 | 0.28798673 |
| 135 | PHKG2 | 0.28798673 |
| 136 | PRKDC | 0.28589353 |
| 137 | PAK1 | 0.28454375 |
| 138 | BMPR1B | 0.26509375 |
| 139 | EPHA4 | 0.25665806 |
| 140 | PLK3 | 0.25526933 |
| 141 | LMTK2 | 0.24989926 |
| 142 | MAP3K12 | 0.24965642 |
| 143 | CDK19 | 0.24946859 |
| 144 | CAMK2D | 0.24365385 |
| 145 | MAP2K7 | 0.24321124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.23003488 |
| 2 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.85168891 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.83982053 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59280148 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.49806062 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.48754283 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.47583450 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.36331468 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.28390449 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.20456912 |
| 11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.19292706 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.15193493 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.07936840 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.03303394 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.99125863 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.96971940 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87514511 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.87059922 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.86540710 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81556150 |
| 21 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79654668 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.78657832 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.74498549 |
| 24 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.73001659 |
| 25 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.69373685 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.67558376 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.62692448 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.62653345 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.62094089 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.60506035 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56919938 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56154439 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.56114085 |
| 34 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.55102550 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51835548 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.47443800 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.45059544 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.40938892 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40265487 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.37751889 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.36366312 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.35399628 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.32498230 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32481537 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.30573822 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.29548141 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.26991288 |
| 48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25312046 |
| 49 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.21688116 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17098457 |
| 51 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16642630 |
| 52 | Cell cycle_Homo sapiens_hsa04110 | 1.14945146 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14175609 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.13864189 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12378715 |
| 56 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.10560903 |
| 57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.06277538 |
| 58 | Protein export_Homo sapiens_hsa03060 | 1.03652749 |
| 59 | Proteasome_Homo sapiens_hsa03050 | 1.01460760 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00756873 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.00194761 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96910923 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94735655 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.94252244 |
| 65 | DNA replication_Homo sapiens_hsa03030 | 0.94235425 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92423435 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91534327 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90430668 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87566134 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84285046 |
| 71 | Mismatch repair_Homo sapiens_hsa03430 | 0.82359614 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.81303732 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78353539 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.78271178 |
| 75 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.76619099 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.76134715 |
| 77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.74869030 |
| 78 | RNA degradation_Homo sapiens_hsa03018 | 0.72630785 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68901091 |
| 80 | RNA polymerase_Homo sapiens_hsa03020 | 0.66426586 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66006035 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65953257 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65756505 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65446196 |
| 85 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65208051 |
| 86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.64544260 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61666800 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.57389047 |
| 89 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.56538878 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.56016703 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55847942 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52407673 |
| 93 | Base excision repair_Homo sapiens_hsa03410 | 0.51378750 |
| 94 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49049220 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47365689 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47310797 |
| 97 | RNA transport_Homo sapiens_hsa03013 | 0.45667201 |
| 98 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44001605 |
| 99 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.40175355 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38084927 |
| 101 | Spliceosome_Homo sapiens_hsa03040 | 0.36247286 |
| 102 | Homologous recombination_Homo sapiens_hsa03440 | 0.33161545 |
| 103 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.29066114 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27005957 |
| 105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.26599671 |
| 106 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.24744475 |
| 107 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23469540 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.23371220 |
| 109 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.22376172 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.21429011 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.21015448 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20094783 |
| 113 | Parkinsons disease_Homo sapiens_hsa05012 | 0.19820423 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18659467 |
| 115 | Purine metabolism_Homo sapiens_hsa00230 | 0.13172304 |
| 116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.08592705 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.05873084 |
| 118 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.05393889 |

